A global conglomerate built on a family legacy.
Company History
Lyfe Group™ is built upon a three-generation family legacy of industry expertise, a strong work ethic and a customer-centric approach. Dedicated to the greater purpose of enhancing life through cutting-edge innovation, education and medical research and development, the company solves complex development challenges for the healthcare industry.
As an international conglomerate spanning multiple companies, Lyfe Group™ has operations in North and South America, Asia and Europe. The history of this fast-paced and dynamic international organization includes many industry innovations.
1984
Lyfe Group™ is established and produces its first gelatin capsules.
1990
Development of an improved immediate-release technology begins.
1995
The medicine and micro-pellets facility opens in Latin America and manufacturing of immediate-response medicine commences.
1996
CapsCanada® innovates its first modified-release dosage forms.
1999
CapsCanada® product portfolio expands to include vegetarian capsules.
2001
CapsCanada® acquires a manufacturing facility in Windsor, Ontario, Canada.
2002
Capsuline© Inc. creates the world’s first global empty capsule eCommerce store.
2006
Innovative flavored capsules are launched.
2011
The production of hard capsules filled with liquids commences.
2014
New state-of-the-art facility for the production of vegetarian capsules initiates operations in Windsor, Ontario, Canada.
2016
CapsCanada® launches AR-Caps® acid-resistant capsules.
2017
CapsCanada® increases capacity with a new facility for manufacturing vegetarian capsules in Latin America.
2018
$28 million invested in new 100,000 square foot K-CAPS® facility to meet rising global demand for these leading vegetarian capsules, resulting in a 50% increase in production capabilities.
2019
CapsCanada® relocates its headquarters and expands its distribution footprint with a new logistics facility. Lyfe Group™ joint ventures with one of Canada’s largest pharmaceutical companies to manufacture holistic therapeutics, increasing manufacturing capacity in Latin America.
2020
As the global COVID-19 pandemic disrupts competitors’ supply chains, Lyfe Group™ continues to reliably provide the high-quality products and services on which its customers depend.